Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breastcance r.
Bottle
Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breastcance r. Lapatinib targets specific receptors involved in cancer cell growth, particularly the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). By inhibiting these receptors, Tykerb helps to slow down or stop the growth of cancer cells.